- Home
- VOR vs DPRO Comparison
VOR vs DPRO Comparison
Compare VOR & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- DPRO
- Stock Information
- Founded
- VOR 2015
- DPRO 1998
- Country
- VOR United States
- DPRO Canada
- Employees
- VOR N/A
- DPRO N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- DPRO Aerospace
- Sector
- VOR Health Care
- DPRO Industrials
- Exchange
- VOR Nasdaq
- DPRO Nasdaq
- Market Cap
- VOR 207.1M
- DPRO 175.1M
- IPO Year
- VOR 2021
- DPRO N/A
- Fundamental
- Price
- VOR $29.40
- DPRO $8.62
- Analyst Decision
- VOR Buy
- DPRO Strong Buy
- Analyst Count
- VOR 6
- DPRO 1
- Target Price
- VOR $85.33
- DPRO $14.00
- AVG Volume (30 Days)
- VOR 526.1K
- DPRO 9.7M
- Earning Date
- VOR 11-06-2025
- DPRO 11-13-2025
- Dividend Yield
- VOR N/A
- DPRO N/A
- EPS Growth
- VOR N/A
- DPRO N/A
- EPS
- VOR N/A
- DPRO N/A
- Revenue
- VOR N/A
- DPRO $5,250,872.00
- Revenue This Year
- VOR N/A
- DPRO $41.59
- Revenue Next Year
- VOR N/A
- DPRO $137.37
- P/E Ratio
- VOR N/A
- DPRO N/A
- Revenue Growth
- VOR N/A
- DPRO 17.08
- 52 Week Low
- VOR $2.62
- DPRO $1.63
- 52 Week High
- VOR $65.80
- DPRO $14.40
- Technical
- Relative Strength Index (RSI)
- VOR 52.41
- DPRO 47.84
- Support Level
- VOR $28.65
- DPRO $11.51
- Resistance Level
- VOR $31.31
- DPRO $13.84
- Average True Range (ATR)
- VOR 3.26
- DPRO 1.84
- MACD
- VOR -1.89
- DPRO -0.33
- Stochastic Oscillator
- VOR 2.79
- DPRO 3.33
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.